Axolotl Biosciences
A start-up biotech company striving to advance in the field of medical science through our novel bioink.
A start-up biotech company striving to advance in the field of medical science through our novel bioink.
Axolotl Biosciences is a biotechnology startup based in Canada, founded in 2020. The company is focused on advancing medical science through its innovative bioink. Axolotl Biosciences offers turn-key reagents such as functional bioinks, 3D tissue models, and consulting services in the field of 3D bioprinting, with the aim of improving human health through novel 3D printing technologies. The most recent investment in the company was a grant from Innovate BC, which was received on 18 January 2023. This investment reflects the confidence that industry stakeholders have in Axolotl Biosciences' potential to make significant strides in the biotech sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | Unknown | 1 | Innovate BC | 18 Jan 2023 |
We care about your data, and we'd love to use cookies make your experience better.